Primecap Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.4M | Sell |
588,710
-324,490
| -36% | -$14M | 0.02% | 230 |
|
|
2025
Q1 | $31.6M | Sell |
913,200
-2,300
| -0.3% | -$79.5K | 0.03% | 207 |
|
|
2024
Q4 | $25.1M | Buy |
915,500
+8,776
| +1% | +$241K | 0.02% | 228 |
|
|
2024
Q3 | $23.1M | Sell |
906,724
-20,176
| -2% | -$514K | 0.02% | 226 |
|
|
2024
Q2 | $23.5M | Sell |
926,900
-330
| -0% | -$8.36K | 0.02% | 224 |
|
|
2024
Q1 | $28.7M | Sell |
927,230
-16,770
| -2% | -$519K | 0.02% | 220 |
|
|
2023
Q4 | $38.1M | Buy |
944,000
+5,300
| +0.6% | +$214K | 0.03% | 199 |
|
|
2023
Q3 | $24.8M | Buy |
938,700
+242,608
| +35% | +$6.4M | 0.02% | 216 |
|
|
2023
Q2 | $12M | Sell |
696,092
-43,900
| -6% | -$755K | 0.01% | 251 |
|
|
2023
Q1 | $12.3M | Sell |
739,992
-173,300
| -19% | -$2.87M | 0.01% | 245 |
|
|
2022
Q4 | $6.96M | Sell |
913,292
-124,438
| -12% | -$948K | 0.01% | 263 |
|
|
2022
Q3 | $10.3M | Sell |
1,037,730
-15,100
| -1% | -$150K | 0.01% | 249 |
|
|
2022
Q2 | $9.56M | Sell |
1,052,830
-79,520
| -7% | -$722K | 0.01% | 254 |
|
|
2022
Q1 | $11.5M | Buy |
1,132,350
+81,610
| +8% | +$828K | 0.01% | 256 |
|
|
2021
Q4 | $17.5M | Buy |
1,050,740
+589,880
| +128% | +$9.84M | 0.01% | 248 |
|
|
2021
Q3 | $21.6M | Buy |
460,860
+14,000
| +3% | +$656K | 0.02% | 238 |
|
|
2021
Q2 | $27.2M | Buy |
446,860
+91,623
| +26% | +$5.59M | 0.02% | 230 |
|
|
2021
Q1 | $21.9M | Buy |
+355,237
| New | +$21.9M | 0.02% | 234 |
|